☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
Pfizer
Pfizer’s Prevenar 20 Receives EC’s Approval for the Protection Against Pneumococcal Disease in Pediatric Population
March 14, 2024
Pfizer Reports P-III Study Results of Adcetris for Treating Diffuse Large B-cell Lymphoma (DLBCL)
March 13, 2024
Pfizer’s Velsipity (etrasimod) Receives the European Commission’s Approval for the Treatment of Severely Active Ulcerative Colitis
February 20, 2024
JP Morgan Special: Dealmaker of the Year 2023 (Part 02)
January 16, 2024
Pfizer’s sBLA for Tivdak Receives the US FDA’s Acceptance for Priority Review to Treat Cervical Cancer
January 10, 2024
Pfizer’s Beqvez (fidanacogene elaparvovec) Receives Health Canada’s Approval for the Treatment of Hemophilia B
January 5, 2024
Load more...
Back to Home